BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18286534)

  • 1. Distinction between isolated tumor cells and micrometastases in breast cancer: is it reliable and useful?
    de Mascarel I; MacGrogan G; Debled M; Brouste V; Mauriac L
    Cancer; 2008 Apr; 112(8):1672-8. PubMed ID: 18286534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
    Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories.
    Pugliese MS; Beatty JD; Tickman RJ; Allison KH; Atwood MK; Szymonifka J; Arthurs ZM; Huynh PP; Dawson JH
    Ann Surg Oncol; 2009 Jan; 16(1):113-20. PubMed ID: 18949520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
    Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
    Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
    Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
    Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.
    Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP
    Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate classification of sentinel lymph node metastases in patients with lobular breast carcinoma.
    Apple SK; Moatamed NA; Finck RH; Sullivan PS
    Breast; 2010 Oct; 19(5):360-4. PubMed ID: 20347308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients.
    Fukagawa T; Sasako M; Shimoda T; Sano T; Katai H; Saka M; Mann GB; Karpeh M; Coit DG; Brennan MF
    Ann Surg Oncol; 2009 Mar; 16(3):609-13. PubMed ID: 19137375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of micrometastases in the sentinel node of patients with invasive breast cancer.
    Hansen NM; Grube B; Ye X; Turner RR; Brenner RJ; Sim MS; Giuliano AE
    J Clin Oncol; 2009 Oct; 27(28):4679-84. PubMed ID: 19720928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
    Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M
    Breast Cancer Res Treat; 2009 Nov; 118(2):385-94. PubMed ID: 19562480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of axillary lymph-node micrometastases in breast cancer patients.
    Kuijt GP; Voogd AC; van de Poll-Franse LV; Scheijmans LJ; van Beek MW; Roumen RM
    Eur J Surg Oncol; 2005 Jun; 31(5):500-5. PubMed ID: 15922886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodal-stage classification in invasive lobular breast carcinoma: influence of different interpretations of the pTNM classification.
    van Deurzen CH; Cserni G; Bianchi S; Vezzosi V; Arisio R; Wesseling J; Asslaber M; Foschini MP; Sapino A; Castellano I; Callagy G; Faverly D; Martin-Martinez MD; Quinn C; Amendoeira I; Kulka J; Reiner-Concin A; Cordoba A; Seldenrijk CA; van Diest PJ
    J Clin Oncol; 2010 Feb; 28(6):999-1004. PubMed ID: 20085942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients.
    Querzoli P; Pedriali M; Rinaldi R; Lombardi AR; Biganzoli E; Boracchi P; Ferretti S; Frasson C; Zanella C; Ghisellini S; Ambrogi F; Antolini L; Piantelli M; Iacobelli S; Marubini E; Alberti S; Nenci I
    Clin Cancer Res; 2006 Nov; 12(22):6696-701. PubMed ID: 17121888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic characteristics of the primary tumor in breast cancer patients with isolated tumor cells of the sentinel node.
    Hulvat M; Rajan P; Rajan E; Sarker S; Schermer C; Aranha G; Yao K
    Surgery; 2008 Oct; 144(4):518-24; discussion 524. PubMed ID: 18847634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis.
    Jinno H; Sakata M; Asaga S; Wada M; Shimada T; Kitagawa Y; Suzuki T; Nakahara T; Kitamura N; Kubo A; Mukai M; Ikeda T; Kitajima M
    Breast J; 2008; 14(6):551-5. PubMed ID: 19000054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.
    Andersson Y; Frisell J; Sylvan M; de Boniface J; Bergkvist L
    J Clin Oncol; 2010 Jun; 28(17):2868-73. PubMed ID: 20458033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation.
    Alkuwari E; Auger M
    Cancer; 2008 Apr; 114(2):89-93. PubMed ID: 18286535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance.
    Rena O; Carsana L; Cristina S; Papalia E; Massera F; Errico L; Bozzola C; Casadio C
    Eur J Cardiothorac Surg; 2007 Dec; 32(6):863-7. PubMed ID: 17936004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the reproducibility of diagnosing micrometastases and isolated tumor cells.
    Cserni G; Bianchi S; Boecker W; Decker T; Lacerda M; Rank F; Wells CA;
    Cancer; 2005 Jan; 103(2):358-67. PubMed ID: 15593354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.